Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.

Co-authored by Principal Investigators at PSI, Professor Moritz Kraemer and Professor Oliver Pybus, a new paper in Proceedings of the National Academy of Sciences may help optimise testing strategies for infectious disease surveillance.

Alongside PSI authors, the study included researchers from the University of Oxford’s Biology and Computer Science departments, as well as colleagues from the Oxford Martin Programme on Pandemic Genomics, Imperial College London, Royal Veterinary College and University of California, Los Angeles.

When epidemics and pandemics occur, screening the population for infection is essential to understand how disease is spreading.

Testing resources, however, are always finite, and questions on how to allocate tests to maximise the information gained about disease distributions remain difficult.

The study proposes a novel machine learning strategy (“policy”), Selection by Local-Entropy (LE), to guide the selection of testing sites. When tested in a range of simulated outbreak scenarios, LE mostly outperformed other testing policies considered by the authors.

Professor Kraemer said: ‘Data and robust understanding of the transmission process early in epidemics are essential for effective public health policies. Our study provides a step towards more rational implementation of public health policies.’

The framework created by this study will allow researchers and policymakers to more adaptively design surveillance systems for infection disease.

Read the full paper on the Proceedings of the National Academy of Sciences website: https://doi.org/10.1073/pnas.2412424121

Similar stories

Deeper understanding of toxic tau could transform dementia treatment

New research from NDM’s Target Discovery Institute, the MRC Laboratory of Molecular Biology and University College London has shed light on a potential pathway for the spread of harmful tau protein in Alzheimer's disease. Their findings, published in Nature Neuroscience, focus on structures called extracellular vesicles and their role in transporting toxic tau fragments.